268 related articles for article (PubMed ID: 28270653)
1. RIP-1/c-FLIPL Induce Hepatic Cancer Cell Apoptosis Through Regulating Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL).
Sun J; Yu X; Wang C; Yu C; Li Z; Nie W; Xu X; Miao X; Jin X
Med Sci Monit; 2017 Mar; 23():1190-1199. PubMed ID: 28270653
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of RIP and c-FLIP in preventing liver cancer cell apoptosis induced by TRAIL.
Sun J; Luo H; Nie W; Xu X; Miao X; Huang F; Wu H; Jin X
Int J Clin Exp Pathol; 2015; 8(6):6519-25. PubMed ID: 26261530
[TBL] [Abstract][Full Text] [Related]
3. 2-DG-Regulated RIP and c-FLIP Effect on Liver Cancer Cell Apoptosis Induced by TRAIL.
Zhang Y; Huang F; Wang J; Luo H; Wang Z
Med Sci Monit; 2015 Nov; 21():3442-8. PubMed ID: 26552967
[TBL] [Abstract][Full Text] [Related]
4. DR5-mediated DISC controls caspase-8 cleavage and initiation of apoptosis in human glioblastomas.
Bellail AC; Tse MC; Song JH; Phuphanich S; Olson JJ; Sun SY; Hao C
J Cell Mol Med; 2010 Jun; 14(6A):1303-17. PubMed ID: 19432816
[TBL] [Abstract][Full Text] [Related]
5. Lipid rafts and nonrafts mediate tumor necrosis factor related apoptosis-inducing ligand induced apoptotic and nonapoptotic signals in non small cell lung carcinoma cells.
Song JH; Tse MC; Bellail A; Phuphanich S; Khuri F; Kneteman NM; Hao C
Cancer Res; 2007 Jul; 67(14):6946-55. PubMed ID: 17638906
[TBL] [Abstract][Full Text] [Related]
6. Catalytically active Yersinia outer protein P induces cleavage of RIP and caspase-8 at the level of the DISC independently of death receptors in dendritic cells.
Gröbner S; Adkins I; Schulz S; Richter K; Borgmann S; Wesselborg S; Ruckdeschel K; Micheau O; Autenrieth IB
Apoptosis; 2007 Oct; 12(10):1813-25. PubMed ID: 17624595
[TBL] [Abstract][Full Text] [Related]
7. Involvement of caspase 8 and c-FLIPL in the proangiogenic effects of the tumour necrosis factor-related apoptosis-inducing ligand (TRAIL).
Cantarella G; Di Benedetto G; Ribatti D; Saccani-Jotti G; Bernardini R
FEBS J; 2014 Mar; 281(5):1505-1513. PubMed ID: 24438025
[TBL] [Abstract][Full Text] [Related]
8. Gli2 silencing enhances TRAIL-induced apoptosis and reduces tumor growth in human hepatoma cells in vivo.
Zhang DW; Li HY; Lau WY; Cao LQ; Li Y; Jiang XF; Yang XW; Xue P
Cancer Biol Ther; 2014; 15(12):1667-76. PubMed ID: 25535898
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of RIP and c-FLIP enhances TRAIL-induced apoptosis in pancreatic cancer cells.
Wang P; Zhang J; Bellail A; Jiang W; Hugh J; Kneteman NM; Hao C
Cell Signal; 2007 Nov; 19(11):2237-46. PubMed ID: 17693058
[TBL] [Abstract][Full Text] [Related]
10. Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs.
Ganten TM; Haas TL; Sykora J; Stahl H; Sprick MR; Fas SC; Krueger A; Weigand MA; Grosse-Wilde A; Stremmel W; Krammer PH; Walczak H
Cell Death Differ; 2004 Jul; 11 Suppl 1():S86-96. PubMed ID: 15105837
[TBL] [Abstract][Full Text] [Related]
11. ShDcR3 sensitizes TRAIL-resistant HCC cells by inducing caspase-dependent apoptosis while suppressing NF-κB dependent cFLIPL expression.
Liang DY; Huang W; Chang Q; Hou YQ
PLoS One; 2018; 13(2):e0191545. PubMed ID: 29444104
[TBL] [Abstract][Full Text] [Related]
12. Progesterone induces apoptosis in TRAIL-resistant ovarian cancer cells by circumventing c-FLIPL overexpression.
Syed V; Mukherjee K; Godoy-Tundidor S; Ho SM
J Cell Biochem; 2007 Oct; 102(2):442-52. PubMed ID: 17393432
[TBL] [Abstract][Full Text] [Related]
13. Metformin sensitizes human bladder cancer cells to TRAIL-induced apoptosis through mTOR/S6K1-mediated downregulation of c-FLIP.
Zhang T; Wang X; He D; Jin X; Guo P
Anticancer Drugs; 2014 Sep; 25(8):887-97. PubMed ID: 24714080
[TBL] [Abstract][Full Text] [Related]
14. The multikinase inhibitor sorafenib potentiates TRAIL lethality in human leukemia cells in association with Mcl-1 and cFLIPL down-regulation.
Rosato RR; Almenara JA; Coe S; Grant S
Cancer Res; 2007 Oct; 67(19):9490-500. PubMed ID: 17909059
[TBL] [Abstract][Full Text] [Related]
15. Suppression of HSP70 expression sensitizes NSCLC cell lines to TRAIL-induced apoptosis by upregulating DR4 and DR5 and downregulating c-FLIP-L expressions.
Zhuang H; Jiang W; Zhang X; Qiu F; Gan Z; Cheng W; Zhang J; Guan S; Tang B; Huang Q; Wu X; Huang X; Jiang W; Hu Q; Lu M; Hua ZC
J Mol Med (Berl); 2013 Feb; 91(2):219-35. PubMed ID: 22948392
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the phenotypes of Jurkat clones with different TRAIL-sensitivities.
Jang YJ; Park KS; Chung HY; Kim HI
Cancer Lett; 2003 May; 194(1):107-17. PubMed ID: 12706864
[TBL] [Abstract][Full Text] [Related]
17. TRAIL induces receptor-interacting protein 1-dependent and caspase-dependent necrosis-like cell death under acidic extracellular conditions.
Meurette O; Rebillard A; Huc L; Le Moigne G; Merino D; Micheau O; Lagadic-Gossmann D; Dimanche-Boitrel MT
Cancer Res; 2007 Jan; 67(1):218-26. PubMed ID: 17210702
[TBL] [Abstract][Full Text] [Related]
18. Differential roles of RelA (p65) and c-Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis-inducing ligand signaling.
Chen X; Kandasamy K; Srivastava RK
Cancer Res; 2003 Mar; 63(5):1059-66. PubMed ID: 12615723
[TBL] [Abstract][Full Text] [Related]
19. Role of IG20 splice variants in TRAIL resistance.
Prabhakar BS; Mulherkar N; Prasad KV
Clin Cancer Res; 2008 Jan; 14(2):347-51. PubMed ID: 18223207
[TBL] [Abstract][Full Text] [Related]
20. Differential responses of FLIPLong and FLIPShort-overexpressing human myeloid leukemia cells to TNF-alpha and TRAIL-initiated apoptotic signals.
Seal S; Hockenbery DM; Spaulding EY; Kiem HP; Abbassi N; Deeg HJ
Exp Hematol; 2008 Dec; 36(12):1660-72. PubMed ID: 18838202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]